TG Therapeutics, Inc. (TGTX)
40.95
+0.79
(+1.97%)
USD |
NASDAQ |
Jun 08, 16:00
41.68
+0.73
(+1.78%)
After-Hours: 05:17
TG Therapeutics Shareholders Equity (Quarterly) : 583.13M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.277B |
| MAIA Biotechnology, Inc. | 27.76M |
| Vericel Corp. | 356.23M |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| United Therapeutics Corp. | 5.901B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.529B |
| Total Liabilities (Quarterly) | 945.71M |
| Debt to Equity Ratio | 1.292 |
| Current Ratio | 5.809 |
| Net Debt Paydown Yield | -1.97% |